Telesis Bio (TBIO) Competitors $0.0010 -0.01 (-91.67%) As of 10:52 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsOptions ChainSEC FilingsShort InterestTrendsBuy This Stock TBIO vs. SMIT, SPEC, THMO, HTGMQ, OLITW, PRENW, QSIAW, SMAPW, TT, and KEYSShould you be buying Telesis Bio stock or one of its competitors? The main competitors of Telesis Bio include Schmitt Industries (SMIT), Spectaire (SPEC), ThermoGenesis (THMO), HTG Molecular Diagnostics (HTGMQ), OmniLit Acquisition (OLITW), Prenetics Global (PRENW), Quantum-Si (QSIAW), SportsMap Tech Acquisition (SMAPW), Trane Technologies (TT), and Keysight Technologies (KEYS). These companies are all part of the "measuring and control equipment" industry. Telesis Bio vs. Its Competitors Schmitt Industries Spectaire ThermoGenesis HTG Molecular Diagnostics OmniLit Acquisition Prenetics Global Quantum-Si SportsMap Tech Acquisition Trane Technologies Keysight Technologies Schmitt Industries (NASDAQ:SMIT) and Telesis Bio (NASDAQ:TBIO) are both small-cap measuring and control equipment companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, risk, institutional ownership, dividends, earnings, analyst recommendations, media sentiment and profitability. Do insiders and institutionals have more ownership in SMIT or TBIO? 37.6% of Telesis Bio shares are held by institutional investors. 17.1% of Schmitt Industries shares are held by company insiders. Comparatively, 24.5% of Telesis Bio shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has better earnings and valuation, SMIT or TBIO? Schmitt Industries has higher earnings, but lower revenue than Telesis Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSchmitt Industries$9.89M0.01-$3.28MN/AN/ATelesis Bio$225.09M0.00-$47.72M-$28.200.00 Which has more risk and volatility, SMIT or TBIO? Schmitt Industries has a beta of -0.44, indicating that its share price is 144% less volatile than the S&P 500. Comparatively, Telesis Bio has a beta of 2.73, indicating that its share price is 173% more volatile than the S&P 500. Is SMIT or TBIO more profitable? Schmitt Industries has a net margin of 0.00% compared to Telesis Bio's net margin of -336.59%. Company Net Margins Return on Equity Return on Assets Schmitt IndustriesN/A N/A N/A Telesis Bio -336.59%N/A -61.89% Does the media refer more to SMIT or TBIO? In the previous week, Telesis Bio had 1 more articles in the media than Schmitt Industries. MarketBeat recorded 1 mentions for Telesis Bio and 0 mentions for Schmitt Industries. Schmitt Industries' average media sentiment score of 0.00 beat Telesis Bio's score of -1.00 indicating that Schmitt Industries is being referred to more favorably in the media. Company Overall Sentiment Schmitt Industries Neutral Telesis Bio Negative SummarySchmitt Industries and Telesis Bio tied by winning 5 of the 10 factors compared between the two stocks. Get Telesis Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TBIO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TBIO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip Chart TBIO vs. The Competition Export to ExcelMetricTelesis BioAnalytical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$2K$1.37M$5.86B$10.15BDividend YieldN/AN/A5.68%4.59%P/E Ratio0.00N/A74.5225.93Price / Sales0.004.56539.62123.65Price / CashN/AN/A37.5660.44Price / Book0.010.0212.166.29Net Income-$47.72M-$54.87M$3.28B$270.77M7 Day PerformanceN/A-11.76%0.98%3.36%1 Month PerformanceN/AN/A7.20%6.41%1 Year PerformanceN/A-3.85%63.06%28.26% Telesis Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TBIOTelesis Bio0.2711 of 5 stars$0.00-91.7%N/A-99.3%$2K$225.09M0.00200Negative NewsShort Interest ↑Gap DownSMITSchmitt IndustriesN/A$0.02flatN/AN/A$69K$9.89M0.00160SPECSpectaireN/A$0.00flatN/A-99.7%$6KN/A0.008THMOThermoGenesisN/AN/AN/AN/A$1K$9.61M0.0040HTGMQHTG Molecular DiagnosticsN/AN/AN/AN/A$0.00$6.37M0.0090OLITWOmniLit AcquisitionN/A$0.07flatN/A-10.3%$0.00N/A0.003PRENWPrenetics GlobalN/A$0.01-43.8%N/A+180.0%$0.00$41.52M0.001Positive NewsQSIAWQuantum-SiN/A$0.48+14.5%N/A+159.3%$0.00$3.41M0.00150Positive NewsShort Interest ↑SMAPWSportsMap Tech AcquisitionN/A$0.03flatN/A+23.2%$0.00N/A0.00N/ATTTrane Technologies4.6369 of 5 stars$407.59-1.9%$458.60+12.5%+17.4%$90.62B$19.84B32.3045,000News CoveragePositive NewsKEYSKeysight Technologies4.5456 of 5 stars$160.09-3.9%$187.38+17.0%+16.4%$27.55B$4.98B50.9815,500Trending NewsAnalyst Revision Related Companies and Tools Related Companies Schmitt Industries Competitors Spectaire Competitors ThermoGenesis Competitors HTG Molecular Diagnostics Competitors OmniLit Acquisition Competitors Prenetics Global Competitors Quantum-Si Competitors SportsMap Tech Acquisition Competitors Trane Technologies Competitors Keysight Technologies Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TBIO) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredDo NOT Day Trade (Do THIS instead)Forget day trading (especially in markets like these). Trade OVERNIGHT instead! I've uncovered a shockin...Monument Traders Alliance | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telesis Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telesis Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TBIO Stock Alerts